Srigen Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 14-12-2024
- Paid Up Capital ₹ 1.30 M
as on 14-12-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 4.70 Cr
as on 14-12-2024
- Revenue -39.18%
(FY 2021)
- Profit -39.82%
(FY 2021)
- Ebitda 2.25%
(FY 2021)
- Net Worth 118.58%
(FY 2021)
- Total Assets 22.94%
(FY 2021)
About Srigen Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.30 M.
The company currently has active open charges totaling ₹4.70 Cr.
Venkat Sirugubattula, Padmajareddy Kallam, Kallam Naveen, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24297TG2010PTC066889
- Company No.
066889
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2010
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Srigen Lifesciences Private Limited offer?
Srigen Lifesciences Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Aroma Chemicals, Chemical Reagents & Catalysts, Organic Compounds, Chemical Intermediates, Pharma Ingredients & Raw Materials, API Intermediate, Pyridine Derivatives.
Who are the key members and board of directors at Srigen Lifesciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkat Sirugubattula  | Managing Director | 09-Oct-2020 | Current |
| Kallam Naveen | Managing Director | 03-Feb-2010 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Padmajareddy Kallam | Director | 03-Feb-2010 | Current |
| Naga Sirugubattula | Director | 05-Oct-2015 | Current |
| Keerthi Vallur | Additional Director | 20-Dec-2021 | Current |
Financial Performance of Srigen Lifesciences.
Srigen Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 39.18% decrease. The company also saw a substantial fall in profitability, with a 39.82% decrease in profit. The company's net worth Soared by an impressive increase of 118.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srigen Lifesciences?
In 2021, Srigen Lifesciences had a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr Sven Laboratories Private LimitedActive 3 years 8 monthsVenkat Sirugubattula and Naga Sirugubattula are mutual person
- Sodum Drugs And Pharmaceuticals Private LimitedActive 7 years 1 month
Keerthi Vallur is a mutual person
- Sree Vishnu Organicsciences Private LimitedActive 4 years 3 months
Keerthi Vallur is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Dec 2018 | ₹0.85 M | Open |
Others Creation Date: 31 Aug 2016 | ₹1.10 M | Open |
Others Creation Date: 25 Jul 2014 | ₹4.50 Cr | Open |
How Many Employees Work at Srigen Lifesciences?
Unlock and access historical data on people associated with Srigen Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srigen Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srigen Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
